Please login to the form below

Not currently logged in
Email:
Password:

David Kendall joins Alimentary Health

He will take up to role of business development director UK
David Kendall

Alimentary Health has appointed David Kendall as its business development director for the UK.

In this newly-created position Kendall will be responsible for the implementation of the Irish healthcare company's business development plans following its UK launch including all of its sales activities and the rollout of the Alforex food supplement in the UK.

Kendall brings to the role over 25 years of commercial experience, having held positions at Chefaro Pharmaceuticals, GlaxoSmithKline, Quest Vitamins and Stiefel Laboratories.

Dr Barry Kiely, chief executive officer of Alimentary Health, said Kendall's new role would be a 'pivotal' one for the company as the company launches operations in new countries.

“As the company continues to expand at pace globally, David's considerable international expertise in healthcare and proven commercial skills make him the ideal candidate to drive our UK expansion.

“We are delighted that David Kendall is now part of Alimentary Health's senior management team.”

19th January 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics